ADAR1 Capital Management »

Nubia Brand Intern -cw27 shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Nubia Brand Intern -cw27 shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Nubia Brand Intern -cw27

Tip: Access up to 7 years of quarterly data

All positions including Nubia Brand Intern -cw27 held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nubia Brand Intern -cw27 by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $634 14k 0.05

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Royalty Pharma Shs Class A (RPRX)
Keros Therapeutics (KROS)
Roivant Sciences SHS (ROIV)
Cytokinetics Com New (CYTK)
Arbutus Biopharma (ABUS)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New (MACK)
Cerevel Therapeutics Hldng I (CERE)
Mirati Therapeutics
Merck & Co (MRK)
Ascendis Pharma A/s Sponsored Adr (ASND)
Immunovant (IMVT)
Viking Therapeutics (VKTX)
Protagonist Therapeutics (PTGX)

View all positions for ADAR1 Capital Management

Top funds holding Nubia Brand Intern -cw27

Exos TFP Holdings
Saba Capital Management
CNH Partners
Polar Securities
Ionic Capital Management
State of Wisconsin Investment Board
D. E. Shaw & Co
Whitebox Advisors
Wolverine Asset Management
Cubist Systematic Strategies
III Capital Management
Citadel Advisors
Millennium Management
ADAR1 Capital Management

View all funds holding Nubia Brand Intern -cw27